Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia

被引:25
作者
Osawa, H
Inoue, F
Yoshida, Y
机构
[1] JICHI MED SCH,OMIYA MED CTR,DEPT SURG,OMIYA,SAITAMA 330,JAPAN
[2] JICHI MED SCH,OMIYA MED CTR,DEPT INTEGRATED MED,OMIYA,SAITAMA 330,JAPAN
关键词
extent of intestinal metaplasia; anti-Helicobacter pylori IgG titre; gastric atrophy;
D O I
10.1136/jcp.49.2.112
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To clarify the relation between the serum titre of anti-Helicobacter pylori (H pylori) antibody and the extent of intestinal metaplasia of the gastric mucosa. Methods-The serum anti-H pylori IgG titres of 95 asymptomatic individuals (mean age 65 years) undergoing an annual health examination were measured and compared with the extent of intestinal metaplasia (absent, moderate, or extensive), determined by examination of multiple endoscopic mucosal biopsy specimens. Serum pepsinogen I (PGI) levels, as a marker for gastric atrophy, were also measured. Results-The prevalence of seropositivity for H pylori antibody was high (>80%), regardless of the extent of metaplasia. However, there was a negative association between the extent of metaplasia and the anti-H pylori titre: 75% of the subjects in the group without metaplasia had high (3 +) antibody levels, as did 43% with moderate, and 37% with extensive metaplasia (absent upsilon extensive). The inverse relation between the titre and the extent of metaplasia was evident when examined in those with normal PGI (>30 ng/ml), whereas no such relation was apparent in subjects with low PGI (less than or equal to 30 ng/ml). Conclusions-The anti-H pylori titre correlates inversely with the extent of intestinal metaplasia, particularly in subjects with less marked gastric atrophy.
引用
收藏
页码:112 / 115
页数:4
相关论文
共 23 条
[1]   RELATIONSHIP OF HELICOBACTER-PYLORI TO SERUM PEPSINOGENS IN AN ASYMPTOMATIC JAPANESE POPULATION [J].
ASAKA, M ;
KIMURA, T ;
KUDO, M ;
TAKEDA, H ;
MITANI, S ;
MIYAZAKI, T ;
MIKI, K ;
GRAHAM, DY .
GASTROENTEROLOGY, 1992, 102 (03) :760-766
[2]  
CORREA P, 1982, CANCER-AM CANCER SOC, V50, P2554
[3]   SUBTYPES OF INTESTINAL METAPLASIA AND HELICOBACTER-PYLORI [J].
CRAANEN, ME ;
BLOK, P ;
DEKKER, W ;
FERWERDA, J ;
TYTGAT, GNJ .
GUT, 1992, 33 (05) :597-600
[4]   EVALUATION OF A COMMERCIAL ELISA FOR SERODIAGNOSIS OF HELICOBACTER-PYLORI INFECTION [J].
CRABTREE, JE ;
SHALLCROSS, TM ;
HEATLEY, RV ;
WYATT, JI .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (04) :326-328
[5]   CAMPYLOBACTER-PYLORI AND PEPTIC-ULCER DISEASE [J].
GRAHAM, DY .
GASTROENTEROLOGY, 1989, 96 (02) :615-625
[6]   EVALUATION OF THE PERFORMANCE OF COMMERCIAL TEST KITS FOR DETECTION OF HELICOBACTER-PYLORI ANTIBODIES IN SERUM [J].
HOEK, FJ ;
NOACH, LA ;
RAUWS, EAJ ;
TYTGAT, GNJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (06) :1525-1528
[7]  
HOWSON CP, 1986, EPIDEMIOL REV, V8, P1
[8]   RADIOIMMUNOASSAY OF SERUM GROUP-I AND GROUP-II PEPSINOGENS IN NORMAL CONTROLS AND PATIENTS WITH VARIOUS DISORDERS [J].
ICHINOSE, M ;
MIKI, K ;
FURIHATA, C ;
KAGEYAMA, T ;
HAYASHI, R ;
NIWA, H ;
OKA, H ;
MATSUSHIMA, T ;
TAKAHASHI, K .
CLINICA CHIMICA ACTA, 1982, 126 (02) :183-191
[9]   CAMPYLOBACTER LIKE ORGANISMS IN DUODENAL AND ANTRAL ENDOSCOPIC BIOPSIES - RELATIONSHIP TO INFLAMMATION [J].
JOHNSTON, BJ ;
REED, PI ;
ALI, MH .
GUT, 1986, 27 (10) :1132-1137
[10]   POSITIVE SERUM ANTIBODY AND NEGATIVE TISSUE-STAINING FOR HELICOBACTER-PYLORI IN SUBJECTS WITH ATROPHIC BODY GASTRITIS [J].
KARNES, WE ;
SAMLOFF, IM ;
SIURALA, M ;
KEKKI, M ;
SIPPONEN, P ;
KIM, SWR ;
WALSH, JH .
GASTROENTEROLOGY, 1991, 101 (01) :167-174